How is active surveillence for low-grade prostate cancer?

• Active surveillance (AS) • Reduce risk of overtreatment of clinically insignificant PCa • But retaining option of definitive therapy for patients – Reclassified over the time as high risk • Overdiagnosis – Many PCa will not progress or cause harm – Diagnosed cases exceed number of lethal cases